eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in eFFECTOR Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −7 vs. Q4 2023
- Shares held
- 938.8K
- +471.4K (+100.8%) vs. Q4 2023Converted for a 1-for-25 split
- Total value
- $13.5M
- +$8.02M (+147.5%) vs. Q4 2023
- New holders
- 6
- 6 more added
- Sold out
- 13
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EFTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 3 | $4.33K |
| Q2 2024 | 18 | $251.1K |
| Q1 2024 | 17 | $13.5M |
| Q4 2023 | 24 | $5.44M |
| Q3 2023 | 29 | $14.0M |
| Q2 2023 | 33 | $20.2M |
| Q1 2023 | 26 | $8.29M |
| Q4 2022 | 30 | $10.4M |
| Q3 2022 | 27 | $13.7M |
| Q2 2022 | 24 | $33.9M |
| Q1 2022 | 19 | $89.7M |
| Q4 2021 | 18 | $174.2M |
| Q3 2021 | 12 | $187.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding eFFECTOR Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 223,000 | $3.21M | 0.09% | +223,000 | New |
| Carlyle Group Inc. | 192,884 | $2.72M | 0.17% | 00.0% | UnchangedConverted for a 1-for-25 split |
| StemPoint Capital LP | 132,793 | $1.91M | 0.51% | +132,793 | New |
| Sectoral Asset Management Inc | 95,305 | $1.37M | 0.54% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Vanguard Group Inc | 92,465 | $1.33M | 0.00% | +69,488+302.4% | AddedConverted for a 1-for-25 split |
| Parallel Advisors, LLC | 67,738 | $974.8K | 0.03% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Blackstone Group Inc. | 52,343 | $753.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Ensign Peak Advisors, Inc | 32,945 | $474.1K | 0.00% | +32,945 | New |
| Geode Capital Management, LLC | 22,609 | $325.4K | 0.00% | +6,290+38.5% | AddedConverted for a 1-for-25 split |
| Raymond James & Associates | 12,345 | $177.6K | 0.00% | +12,345 | New |
| Sea Otter Advisors LLC | 10,557 | $151.9K | 0.79% | +10,557 | New |
| Morgan Stanley | 1,615 | $23.2K | 0.00% | +895+124.3% | AddedConverted for a 1-for-25 split |
| Tower Research Capital LLC (TRC) | 1,534 | $22.1K | 0.00% | +1,487+3,183.4% | AddedConverted for a 1-for-25 split |
| Royal Bank of Canada | 432 | $6.00K | 0.00% | +426+7,348.3% | AddedConverted for a 1-for-25 split |
| ICA Group Wealth Management, LLC | 247 | $3.56K | 0.00% | +247 | New |
| Wells Fargo & Company | 19 | $273 | 0.00% | +6+51.3% | AddedConverted for a 1-for-25 split |
| Qube Research & Technologies Ltd | 3 | $43 | 0.00% | −0−7.4% | ReducedConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −6,432−100.0% | Sold outConverted for a 1-for-25 split |
| Sonora Investment Management Group, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −2,468−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −1,235−100.0% | Sold outConverted for a 1-for-25 split |
| Wescott Financial Advisory Group, LLC | 0 | $0 | 0.00% | −1,222−100.0% | Sold outConverted for a 1-for-25 split |
| Stifel Financial Corp | 0 | $0 | 0.00% | −906−100.0% | Sold outConverted for a 1-for-25 split |
| Callan Capital, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold outConverted for a 1-for-25 split |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −600−100.0% | Sold outConverted for a 1-for-25 split |
| UBS Group AG | 0 | $0 | 0.00% | −364−100.0% | Sold outConverted for a 1-for-25 split |
| BlackRock Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold outConverted for a 1-for-25 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-25 split |
| Bank of America Corp | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-25 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −69−100.0% | Sold outConverted for a 1-for-25 split |